| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
| mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.0093 |
1 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.0034 |
1 |